GAITHERSBURG, Md. and SUZHOU BIOBAY, China, Nov. 16, 2021 /PRNewswire/ — Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that it will be presenting positive results from a…